Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in Chronic Low Back Pain (Japan)
NCT01855919Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of duloxetine in chronic low back pain (CLBP), sponsored by Eli Lilly and Company. Started May 2013; status: completed.
02
Drugs
duloxetine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT01855919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01855919.